Quality of Life With Bone Conduction Hearing Device

Status Recruiting

Clinical Trial Summary

The aim of this study is to compare the audiological and quality of life performance patients have with an ADHEAR (adhesive bone conduction device) compared to no hearing device.

Clinical Trial Description

Patients will be recruited at the outpatient's department of the Medical University of Vienna - Otorhinolaryngology department. Patient will be asked to participate in the study when inclusion and exclusion criteria are met. Mostly patients scheduled for a surgery improving conductive hearing loss or scheduled for implantation of an implantable bone conduction hearing aid will be included in the study. Patients who do not use a hearing aid and who are not planning on using a hearing aid meeting the inclusion and exclusion criteria will also be asked to participate in the study. After inclusion in the study patients will be asked to fill out two questionnaires (quality of life and hearing specific questionnaire). They will then be fitted with an ADHEAR device and undergo unaided and aided soundfield audiometry. Randomization will be carried out (Randomization ratio 1.4:1) and patients in the intervention group will keep the device for the following 4 months with one visit after the first probation time of one month. At the one month mark patients in the control group will be asked to fill out the two questionnaires. Patients in the control group will be asked to return to the department and fill out the three questionnaires (SSQ-12 (Speech Spatial and Hearing Questionnaire), AQoL(Assessment of Quality of Life) and In-house questionnaire). Further audiologic assessment will be carried out. At this appointment patients will be able to talk about their experiences in the probation period und easily terminate the study in case of insufficient improvement, pain, skin irritations or other issues. At the four month mark patients in both groups will be asked to return for audiologic assessment and for filling out the questionnaires. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03864731
Study type	Interventional
Source	Medical University of Vienna
Contact	Valerie Dahm, MD
Phone	+4314040033300
Email	valerie.dahm@meduniwien.ac.at
Status	Recruiting
Phase	N/A
Start date	February 25, 2019
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03723161` - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed	`NCT04320407` - Osia CPT Code Study	N/A
Active, not recruiting	`NCT01445977` - SoundBite Hearing System Long Term Multi Site Patient Use Study	N/A
Completed	`NCT02304692` - Clinical Survey of Different Abutment Topologies	N/A
Recruiting	`NCT00393159` - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children	Phase 4
Recruiting	`NCT06164184` - Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss
Not yet recruiting	`NCT01967498` - Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study	N/A
Active, not recruiting	`NCT05628285` - Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear	N/A
Completed	`NCT03374787` - Evaluation of Sound Processor for a Transcutaneous System	N/A
Completed	`NCT02092610` - Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System	N/A
Completed	`NCT01671176` - Wide Diameter Bone Anchored Implant Study	N/A
Completed	`NCT03086135` - Clinical Performance of a New Implant System for Bone Conduction Hearing	N/A
Recruiting	`NCT01807559` - SoundBite Hearing System 24 Month Multi Site Patient Use Study	N/A
Withdrawn	`NCT01264510` - Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)	Phase 4
Recruiting	`NCT04803279` - Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Completed	`NCT03143257` - Ambispective Clinical Evaluation of Sophono™
Completed	`NCT02274129` - Clinical Survey of Oticon Medical Healing Cap	N/A
Withdrawn	`NCT03541967` - Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband	N/A
Recruiting	`NCT03327194` - Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss	N/A
Completed	`NCT05000931` - Osia 2 Pediatric Expansion Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.